Our medical practice is pleased to offer Semaglutide GLP-1 therapy as an effective weight-loss treatment option for appropriate candidates
MPs heard in June 2026 that just 1% of eligible patients are accessing weight-loss services on the NHS
Table 20: Treatment Effect for the Primary Composite Endpoint* and its Components* in the DAPA-HF and DELIVER Trials (Overall Population) Figure 7: Time to the First Occurrence of the Composite of Cardiovascular Death*, Hospitalization for Heart Failure or Urgent Heart Failure Visit DAPA-HF Trial NOTE: An urgent heart failure visit was defined as an urgent, unplanned, assessment by a physician, e.g., in an Emergency Department, and requiring treatment for worsening heart failure (other than just an increase in oral diuretics)
Semaglutide has known contraindications and interactions that require clinical assessment
2019;42(Supplement 1):S6170
Youre looking at 4-8 weeks before you notice initial improvements in skin texture, fine lines, wrinkles, and overall appearance